These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17235298)

  • 41. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is oncolytic virotherapy?
    Cockle JV; Scott KJ
    Arch Dis Child Educ Pract Ed; 2018 Feb; 103(1):43-45. PubMed ID: 28588023
    [No Abstract]   [Full Text] [Related]  

  • 43. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
    Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: oncolytic viruses.
    Jia W
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1731. PubMed ID: 22856874
    [No Abstract]   [Full Text] [Related]  

  • 45. Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.
    Deng H; Tang N; Stief AE; Mehta N; Baig E; Head R; Sleep G; Yang XZ; McKerlie C; Trudel S; Stewart AK; McCart JA
    Leukemia; 2008 Dec; 22(12):2261-4. PubMed ID: 18509356
    [No Abstract]   [Full Text] [Related]  

  • 46. Turning killer into cure -- the story of oncolytic herpes simplex viruses.
    Zhang SX
    Discov Med; 2015 Nov; 20(111):303-9. PubMed ID: 26645902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From virotherapy to oncolytic immunotherapy: where are we now?
    Coffin RS
    Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
    Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
    J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.
    Cattaneo R; Miest T; Shashkova EV; Barry MA
    Nat Rev Microbiol; 2008 Jul; 6(7):529-40. PubMed ID: 18552863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer.
    Bell JC; McFadden G
    Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinoma.
    Fu X; Nakamori M; Tao L; Amato R; Zhang X
    Int J Oncol; 2007 Jun; 30(6):1561-7. PubMed ID: 17487379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Progress in using Newcastle disease virus for tumor therapy: a review].
    Wu Y; Hao J; Li D
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1031-6. PubMed ID: 21090105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncolytic viruses: smart therapeutics for smart cancers.
    Auer R; Bell JC
    Future Oncol; 2012 Jan; 8(1):1-4. PubMed ID: 22149027
    [No Abstract]   [Full Text] [Related]  

  • 55. ReVOLT: radiation-enhanced viral oncolytic therapy.
    Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncolytic virotherapy.
    Sze DY; Reid TR; Rose SC
    J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
    Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
    Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018.
    Abei M
    Curr Cancer Drug Targets; 2018; 18(2):108. PubMed ID: 29457568
    [No Abstract]   [Full Text] [Related]  

  • 59. Oncolytic viruses: now interviewing for the all-star game.
    Vile R
    Mol Ther; 2010 May; 18(5):866-8. PubMed ID: 20436492
    [No Abstract]   [Full Text] [Related]  

  • 60. For the Success of Oncolytic Viruses: Single Cycle Cures or Repeat Treatments? (One Cycle Should Be Enough).
    Russell SJ
    Mol Ther; 2018 Aug; 26(8):1876-1880. PubMed ID: 30029891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.